Scarica l'app Stockscreener
1.46
10.61%
0.14
Dopo l'orario di chiusura:
1.57
0.11
+7.53%
Precedente Chiudi:
$1.32
Aprire:
$1.32
Volume 24 ore:
317.30K
Relative Volume:
0.49
Capitalizzazione di mercato:
$98.01M
Reddito:
-
Utile/perdita netta:
$-46.12M
Rapporto P/E:
-1.6894
EPS:
-0.8642
Flusso di cassa netto:
$-41.02M
1 W Prestazione:
+4.29%
1M Prestazione:
+8.96%
6M Prestazione:
-14.12%
1 anno Prestazione:
-5.81%
Intervallo 1D:
$1.32
$1.46
Intervallo di 1 settimana:
$1.30
$1.71
Portata 52W:
$0.7113
$2.815
Inflarx N V Stock (IFRX) Company Profile
Confronta IFRX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
IFRX
Inflarx N V
|
1.46 | 89.43M | 0 | -46.12M | -41.02M | -0.8642 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Inflarx N V Stock (IFRX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-09-02 | Ripresa | H.C. Wainwright | Buy |
| 2025-05-29 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2025-04-29 | Iniziato | Cantor Fitzgerald | Overweight |
| 2023-04-05 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2022-02-28 | Downgrade | Guggenheim | Buy → Neutral |
| 2021-10-28 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2021-03-11 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2020-11-06 | Aggiornamento | SVB Leerink | Mkt Perform → Outperform |
| 2020-10-08 | Iniziato | H.C. Wainwright | Buy |
| 2020-06-17 | Iniziato | BTIG Research | Buy |
| 2020-04-30 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2019-06-05 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| 2019-06-05 | Downgrade | Guggenheim | Buy → Neutral |
| 2019-06-05 | Downgrade | JP Morgan | Overweight → Underweight |
| 2019-06-05 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2019-06-05 | Downgrade | SunTrust | Buy → Hold |
| 2019-01-29 | Iniziato | Robert W. Baird | Outperform |
| 2018-12-10 | Iniziato | Credit Suisse | Outperform |
| 2018-07-13 | Iniziato | BMO Capital Markets | Outperform |
| 2018-06-28 | Iniziato | Raymond James | Outperform |
| 2018-06-28 | Iniziato | SunTrust | Buy |
| 2018-02-08 | Iniziato | B. Riley FBR, Inc. | Buy |
Mostra tutto
Inflarx N V Borsa (IFRX) Ultime notizie
Can InflaRx N.V. recover in the next quarter2025 Trading Recap & Risk Controlled Swing Alerts - newser.com
Why InflaRx N.V. stock remains a top recommendationJuly 2025 Volume & Consistent Growth Equity Picks - newser.com
Reversal indicators forming on InflaRx N.V. stock2025 Sector Review & Daily Chart Pattern Signal Reports - newser.com
How geopolitical tensions affect InflaRx N.V. stockJuly 2025 Highlights & Low Risk Entry Point Tips - newser.com
How InflaRx N.V. stock performs after earningsGap Up & Safe Capital Allocation Plans - newser.com
Volatility clustering patterns for InflaRx N.V.Recession Risk & Technical Pattern Recognition Alerts - newser.com
InflaRx NV IF0 Stock Analysis and ForecastEarnings Growth Projections & Learn to Think Like a Long-Term Investor - earlytimes.in
InflaRx N.V. (NASDAQ:IFRX) Short Interest Update - MarketBeat
How reliable is InflaRx N.V. (IF0) stock dividend growthIPO Watch & Daily Profit Maximizing Tips - newser.com
Will InflaRx N.V. (IF0) stock deliver compounding returnsIPO Watch & Free Growth Oriented Trading Recommendations - newser.com
Institutional scanner results for InflaRx N.V.July 2025 PreEarnings & Stock Portfolio Risk Control - newser.com
Can InflaRx N.V. stock rebound after recent weaknessTrade Volume Summary & Daily Chart Pattern Signals - newser.com
Will InflaRx N.V. (IF0) stock outperform benchmarksJuly 2025 Short Interest & AI Powered Market Entry Ideas - newser.com
Will InflaRx N.V. (IF0) stock deliver stable dividends2025 Winners & Losers & High Win Rate Trade Tips - newser.com
What hedge fund moves indicate for InflaRx N.V. (IF0) stockJuly 2025 Review & Real-Time Chart Breakout Alerts - newser.com
InflaRx N.V. (NASDAQ:IFRX) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
Why InflaRx N.V. stock remains resilient2025 Investor Takeaways & Weekly Watchlist for Consistent Profits - fcp.pa.gov.br
Edesa Biotech and InflaRx: Advancing ARDS Treatment with Bevacizumab - MSN
Can InflaRx N.V. stock maintain operating marginsQuarterly Trade Report & Short-Term High Return Ideas - Fundação Cultural do Pará
What makes InflaRx N.V. stock attractive to growth funds2025 Top Gainers & Reliable Price Breakout Alerts - newser.com
Edesa Biotech and InflaRx: Advancing ARDS Treatment with Vilobelimab - TipRanks
What catalysts could drive InflaRx N.V. stock higherQuarterly Earnings Report & High Conviction Trade Alerts - Fundação Cultural do Pará
Inflarx N V Azioni (IFRX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.62%
0.21%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):